FR5806M - - Google Patents

Info

Publication number
FR5806M
FR5806M FR72315A FR72315A FR5806M FR 5806 M FR5806 M FR 5806M FR 72315 A FR72315 A FR 72315A FR 72315 A FR72315 A FR 72315A FR 5806 M FR5806 M FR 5806M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR72315A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT934165A external-priority patent/AT260240B/en
Application filed filed Critical
Application granted granted Critical
Publication of FR5806M publication Critical patent/FR5806M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
FR72315A 1965-05-08 1966-08-05 Expired FR5806M (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEC0035799 1965-05-08
DEC0037133 1965-10-12
DEC0037142 1965-10-13
AT934165A AT260240B (en) 1965-10-15 1965-10-15 Process for the preparation of new dicarboximide derivatives and salts of these compounds

Publications (1)

Publication Number Publication Date
FR5806M true FR5806M (en) 1968-02-19

Family

ID=27422273

Family Applications (2)

Application Number Title Priority Date Filing Date
FR60670A Expired FR1592059A (en) 1965-05-08 1966-05-06
FR72315A Expired FR5806M (en) 1965-05-08 1966-08-05

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR60670A Expired FR1592059A (en) 1965-05-08 1966-05-06

Country Status (8)

Country Link
BE (1) BE680696A (en)
CH (1) CH478117A (en)
FR (2) FR1592059A (en)
GB (1) GB1075420A (en)
IL (1) IL25595A (en)
NO (1) NO123088B (en)
OA (1) OA01951A (en)
PH (1) PH10158A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644066A (en) * 1968-09-18 1987-02-17 Raychem Corporation Flame retardants and compositions containing them
US4581396A (en) * 1968-09-18 1986-04-08 Raychem Corporation Flame retardants and compositions containing them
US4535170A (en) * 1968-09-18 1985-08-13 Raychem Corporation Flame retardants and compositions containing them
US4374220A (en) 1968-09-18 1983-02-15 Raychem Corporation Imide flame retardants and compositions containing them
DE2003608A1 (en) * 1970-01-28 1971-08-05 Gruenenthal Chemie New heterocyclic compounds and processes for their preparation
BR9908811A (en) * 1998-03-16 2000-12-05 Celgene Corp Compound, pharmaceutical composition and its use in the treatment of mammals
EP1389203B8 (en) 2001-02-27 2010-03-10 The Governement of the United States of America, represented by The Secretary Department of Health and Human services Analogs of thalidomide as angiogenesis inhibitors
ES2172474B1 (en) * 2001-03-01 2004-01-16 Fundacion Universitaria San Pa GLUTARIMIDE DERIVATIVES AS THERAPEUTIC AGENTS.
WO2005016326A2 (en) * 2003-07-11 2005-02-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
CN1867331B (en) 2003-09-17 2010-05-26 美国政府健康及人类服务部 Thalidomide analogs as TNF-alpha modulators
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CA2648216C (en) 2006-04-13 2016-06-07 Michael Gutschow Tetrahalogenated compounds useful as inhibitors of angiogenesis
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Also Published As

Publication number Publication date
FR1592059A (en) 1970-05-11
OA01951A (en) 1970-02-04
NO123088B (en) 1971-09-27
IL25595A (en) 1971-01-28
GB1075420A (en) 1967-07-12
BE680696A (en) 1966-11-07
PH10158A (en) 1976-09-13
CH478117A (en) 1969-09-15

Similar Documents

Publication Publication Date Title
FR5806M (en)
JPS4322514Y1 (en)
JPS438908Y1 (en)
JPS4424806Y1 (en)
AU5800565A (en)
JPS44571Y1 (en)
JPS4524426Y1 (en)
BE661591A (en)
BE664766A (en)
BE674559A (en)
BE674647A (en)
BE674676A (en)
SE311361B (en)
BE674244A (en)
BE674683A (en)
BE674427A (en)
AU6783465A (en)
BE629703A (en)
BE657977A (en)
BE658570A (en)
BE660387A (en)
BE670827A (en)
BE661289A (en)
NL131634C (en)
BE671386A (en)